Ypsomed Holding AG (FRA:OWX)

Market Cap	5.06B
Revenue (ttm)	841.79M
Net Income (ttm)	207.36M
Shares Out	n/a
EPS (ttm)	15.19
PE Ratio	24.38
Forward PE	25.76
Dividend	2.35 (0.68%)
Ex-Dividend Date	Jul 4, 2025

Volume	n/a
Average Volume	3
Open	346.50
Previous Close	347.50
Day's Range	346.50 - 346.50
52-Week Range	120.60 - 469.50
Beta	n/a
RSI	69.46
Earnings Date	Feb 11, 2026

About Ypsomed Holding AG

Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication companies. The company operates through three segments: Ypsomed Delivery Systems, Ypsomed Diabetes Care, and Others. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto-injectors, and wearable injectors, as well as other smart devices. This segment offers its products under the YDS brand. The Ypsomed Diabetes Care segment sells and trades in insu...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1984
• Employees: 2,644
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: OWX

Financial Performance

In 2024, Ypsomed Holding AG's revenue was 748.87 million, an increase of 36.54% compared to the previous year's 548.46 million. Earnings were 87.50 million, an increase of 11.66%.

Financial numbers in CHF